Article
Next Generation Sequencing is a Reliable Tool for Detecting BRCA1/2 Mutations, Including Large Genomic Rearrangements.
Clinical laboratory - 1 Feb 2022
Lee Jae Hee, Ryoo Nam-Hee, Ha Jung-Sook, Park Sunggyun, Kim Kyoung Bo, Kang Sun Hee, Kim Do-Hoon
Abstract excerpt
BACKGROUND: Next-generation sequencing (NGS) has been implemented as a rapid and cost-effective BRCA1/2 test strategy. The Oncomine™ BRCA Research Assay is an NGS-based tool for simultaneous detection of small-scale mutations and large genomic rearrangements (LGRs). We evaluated this NGS assay using different versions of Ion Reporter™ (IR) software. METHODS: A total of 258 patients with breast, ovarian, primary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
